Thor Medical ASA: Invitation to Presentation of Half-Year 2026 Results

19.8.2026 07:00:08 CEST | Thor Medical ASA | Non-regulatory press releases
Thor Medical ASA will publish its financial results for the first half of 2026 on Friday, August 28, 2026, at 07:00 CEST.
The company will host a presentation of the results at 08:00 CEST on the same day at Sjølyst Møtesenter, Drammensveien 165, Oslo. Investors, analysts and media are invited to attend.
Date: Friday, August 28, 2026Time: 08:00 CESTVenue: Sjølyst Møtesenter, Drammensveien 165, OsloWebcast: https://qcnl.tv/p/fw_5KqTHcjfYMddAq3–1A
The financial report for the first half of 2026 and the presentation material will be published at 07:00 CEST and will be available at www.thormedical.com.
Contacts

Mathias Nilsen Reierth, Head of Communications and Corporate Affairs, +47 988 05 724, mathias.reierth@thormedical.com

About Thor Medical ASA
ABOUT THOR MEDICAL ASA
Thor Medical is a leading supplier of high-purity isotopes to the radiopharmaceutical industry. The Company’s proprietary production platform combines advanced separation technology with industrial-scale manufacturing capacity to deliver a reliable, scalable and cost-efficient supply of alpha-emitting radioisotopes. Thor Medical supports radiopharmaceutical companies from early-stage development to commercialization enabling scale-up of next-generation targeted cancer therapies.
Thor Medical’s product portfolio includes lead-212 (Pb-212) and its precursor isotopes thorium-228 (Th-228) and radium-224 (Ra-224). Based on naturally occurring thorium, Thor Medical’s production process requires neither irradiation nor nuclear reactors, providing significant cost advantages while minimizing radioactive waste.
Guided by its vision to become a world-leading enabler for targeted cancer therapies, Thor Medical is committed to improving millions of lives by powering the next generation of precision cancer treatment with high-purity isotopes.
Thor Medical is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange under the ticker symbol TRMED. For more information, visit www.thormedical.com.
Attachments

Download announcement as PDF.pdf

Leave a Reply